Farajzadeh Sheikh Ahmad, Shahin Mojtaba, Shokoohizadeh Leili, Ghanbari Fahimeh, Solgi Hamid, Shahcheraghi Fereshteh
Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Iran J Public Health. 2020 May;49(5):959-967.
New Delhi metallobetalactamase1 (NDM-1) is one of the most important emerging antibiotic resistance. Co-harboring three or four carbapenemases is rare and only a few reports exist in the literature. We described the characteristics of the large epidemic outbreaks and reports co-producing with the other carbapenemase genes in isolates.
This present cross-sectional research was conducted on 369 isolates obtained from burn and general hospitals within years 2013 to 2016. Beta-lactamase classes A, B and D genes were identified by PCR method. Modified hodge test (MHT), double-disk potentiation tests (DDPT) and double disk synergy test (DDST) were performed for detection carbapenemase and metallo beta-lactamase (MBL) production of positive isolates.
From 236 carbapenem-resistant (CRPA), 116 isolates have had MBL genes and twenty-nine isolates were found positive for . In CRPA isolates, , and were identified in 27.5%, 21.1% and 32.2% of isolates respectively, while co-producing , , , co-producing , , and co-producing , were determined in 11 (4.6%), 8 (3.4%) and 27 (11.4%) of isolates respectively.
The finding of this co-existence of multiple carbapenemase resistance genes is threating for public health. Dipicolinic acid is a superior MBL inhibitor in DDPT antique than EDTA in DDST method for the detection of MBL- producing .
新德里金属β-内酰胺酶1(NDM-1)是最重要的新出现的抗生素耐药性之一。同时携带三种或四种碳青霉烯酶的情况很少见,文献中仅有少数报道。我们描述了在分离株中与其他碳青霉烯酶基因共同产生的大流行暴发特征及报道。
本横断面研究对2013年至2016年期间从烧伤医院和综合医院获得的369株分离株进行。通过PCR方法鉴定A、B和D类β-内酰胺酶基因。对阳性分离株进行改良 Hodge试验(MHT)、双纸片增效试验(DDPT)和双纸片协同试验(DDST)以检测碳青霉烯酶和金属β-内酰胺酶(MBL)的产生情况。
在236株耐碳青霉烯类肺炎克雷伯菌(CRPA)中,116株分离株携带MBL基因,29株分离株检测到 blaNDM-1阳性。在CRPA分离株中,blaVIM、blaIMP和blaOXA-48分别在27.5%、21.1%和32.2%的分离株中被鉴定出来,而同时产生 blaNDM-1、blaVIM,同时产生 blaNDM-1、blaIMP,以及同时产生 blaNDM-1、blaOXA-48分别在11株(4.6%)、8株(3.4%)和27株(11.4%)分离株中被检测到。
多种碳青霉烯酶耐药基因共存的这一发现对公共卫生构成威胁。在DDPT试验中,吡啶二羧酸作为MBL抑制剂比DDST方法中的EDTA更具优势,可用于检测产MBL的菌株。